2'-cyano-2'-deoxyarabinofuranosylcytosine has been researched along with troxacitabine in 1 studies
Studies (2'-cyano-2'-deoxyarabinofuranosylcytosine) | Trials (2'-cyano-2'-deoxyarabinofuranosylcytosine) | Recent Studies (post-2010) (2'-cyano-2'-deoxyarabinofuranosylcytosine) | Studies (troxacitabine) | Trials (troxacitabine) | Recent Studies (post-2010) (troxacitabine) |
---|---|---|---|---|---|
31 | 0 | 6 | 72 | 17 | 2 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Liu, X; Matsuda, A; Plunkett, W; Wang, Y | 1 |
1 other study(ies) available for 2'-cyano-2'-deoxyarabinofuranosylcytosine and troxacitabine
Article | Year |
---|---|
Repair of 2'-C-cyano-2'-deoxy-1-beta-D-arabino-pentofuranosylcytosine-induced DNA single-strand breaks by transcription-coupled nucleotide excision repair.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; CHO Cells; Cricetinae; Cricetulus; Cytarabine; Cytosine; Dioxolanes; DNA Damage; DNA Repair; HeLa Cells; Humans; Mice; Transcription, Genetic; Tumor Suppressor Protein p53 | 2008 |